List of plenary lectures
- Corrado Angelini (Department of Neurology, University of Padua, Padua, Italy): State of the Art in Muscle Glycogenoses.
- Stanley Appel (Department of Neurology, The Methodist Hospital, Houston, United States of America USA): The current state of knowledge of ALS: pathogenesis and treatment
- Valerie Askanas (U.S.C. Neuromuscular Center, Los Angeles, CA, USA): Inclusion-Body Myositis: Newest Pathogenic Findings Paving the Way to Possible Treatments
- Kate Bushby (University of Newcastle, Newcastle, UK): State of the art in human muscular dystrophies
- Kevin Campbell (Department of Molecular Physiology & Biophysics. University of Iowa, Iowa City, USA): New advances in the pathogenesis of muscular dystrophies
- Marinos Dalakas (Imperial College, London, UK ): Immunopathology of Inflammatory Myopathies – Mechanisms and Best Treatments
- Salvatore Di Mauro (Department of Neurology, Columbia University College of Physicians & Surgeons, USA) : Recent advances in understanding pathogenesis and treatment of Mitochondrial Myopathies
- PA Van Doorn (Department of Neurology, University Hospital Rotterdam, The Netherlands NL): Dysimmune polyneuropathies: From Cell Biology to Rational Therapies
- Robert C. Griggs (University of Rochester School of Medicine and Dentistry, Rochester, N.Y. USA): Therapeutic Trials in NMD: Challenges and (Some) Solutions
- Eric Hoffman (Children's National Medical Center , Washington, Washington DC, USA): Newest Approaches to Treatment of Muscular Dystrophies
- Frank Lehmann-Horn (University of Ulm, Germany): State of the Art in muscle channellopathies
- Hanns Lochmuller (University of Newcastle, Newcastle, UK): The Neuromuscular Junction and Congenital Myasthenic Syndromes
- Judith Melki (Department of Human Genetics, Hadassah University Hospital, Jerusalem, Israel): SMA: clinical relevance of the animal and cellular models regarding pathogenesis and treatment
- Francesco Muntoni (Imperial College of London, London UK): State of the art in human congenital muscular dystrophies
- Ichizo Nishino (National Center of Neurology and Psychiatry, Tokyo, Japan): State of the Art in Muscle Lipid Diseases
- Giuseppe Novelli (Univerity of Tor Vergata, Rome, Italy): State of the art in laminopathies
- Massimo Pandolfo (Service de Neurologie, Hospital Erasme, Université Libre de Bruxelles, Belgium) :State of the Art in Friedreich's ataxia
- Michael Shy (Wayne State University, Detroit, MI, USA): Hereditary Neuropathies: From Cell Biology to Rational Therapies
- Charles Thornton (University of Rochester School of Medicine and Dentistry, Rochester, N.Y. USA): Myotonic Dystrophy: Newest Molecular Aspects of Pathogenesis and Possible treatment
- Angela Vincent (Department of Neurology, University of Oxford, Oxford, UK): Clinical and serological subgroups of Myasthenia Gravis and their relevance to formulating treatment
|
